New antifungal looks safer than liposomal amphotericin B
FONTE
BMJ Publishing Group Ltd.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1865403Documentos Relacionados
- Rabbit Model of Candida albicans Biofilm Infection: Liposomal Amphotericin B Antifungal Lock Therapy
- Synergistic antifungal activity and reduced toxicity of liposomal amphotericin B combined with gramicidin S or NF.
- Liposomal amphotericin B in hepatic candidosis.
- Liposomal amphotericin B therapy of murine histoplasmosis.
- Activity of liposomal amphotericin B against experimental cutaneous leishmaniasis.